Blue cone monochromacy (BCM) is a rare X-linked retina disorder. It causes a complete or near-complete loss of function in the L- and M-cones responsible for color vision. As a result, individuals ...

rod monochromacy, in which none of the three types of cones, L (long wavelength-sensitive)-, M (middle wavelength-sensitive)- or S (short wavelength-sensitive)-cones, are functional; (2 ...

7m8-L-opsin), a novel gene therapy product candidate being developed as a potential single intravitreal (IVT) administration for blue cone monochromacy ... Laurent Fischer, M.D., president ...

(HealthDay)—Imagine a world in black and white. That's the plight of people with an extremely rare condition called blue cone monochromacy, an inherited eye disease that renders people unable to ...

ADVM-062, a novel gene therapy candidate, received orphan drug designation from the FDA for the treatment of blue cone monochromacy, according to a press release from Adverum Biotechnologies.

Blue Cone Monochromacy, a rare form of colorblindness, affects 1 in 100,000 individuals. It leads to poor or no color discrimination, which is why the photo above looks sort of like it’s been ...

7m8-L-opsin), a novel gene therapy product candidate being developed as a potential single intravitreal (IVT) administration for blue cone monochromacy ... Laurent Fischer, M.D., president ...